Pulmonary Hypertension (PH) Terminated Phase 3 Trials for Tezosentan (DB06558)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00458276Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart SurgeryTreatment